Nuveen Asset Management, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,084,232
-11.5%
263,835
+1.8%
0.00%0.0%
Q2 2023$3,483,702
+79309.7%
259,204
-2.0%
0.00%
-50.0%
Q1 2023$4,387
-74.5%
264,571
-71.4%
0.00%
-71.4%
Q4 2022$17,221
-99.9%
925,877
-33.1%
0.01%0.0%
Q3 2022$17,754,000
+74.7%
1,383,789
-4.6%
0.01%
+75.0%
Q2 2022$10,162,000
+85.4%
1,449,757
+107.6%
0.00%
+100.0%
Q1 2022$5,480,000
+17.0%
698,181
-4.2%
0.00%
+100.0%
Q4 2021$4,683,000
+15.6%
728,934
-9.1%
0.00%0.0%
Q3 2021$4,052,000
-22.6%
802,283
-11.9%
0.00%
-50.0%
Q2 2021$5,238,000
+29.5%
910,965
+3.8%
0.00%
+100.0%
Q1 2021$4,045,000
+32.1%
877,481
-4.3%
0.00%0.0%
Q4 2020$3,063,000
+168.9%
916,829
+139.0%
0.00%
Q3 2020$1,139,000
-35.4%
383,547
+0.5%
0.00%
-100.0%
Q2 2020$1,763,000
+14.6%
381,637
-4.5%
0.00%0.0%
Q1 2020$1,538,000
-80.9%
399,418
-81.4%
0.00%
-66.7%
Q4 2019$8,061,000
+278.6%
2,149,533
+436.1%
0.00%
+200.0%
Q3 2019$2,129,000
+40.5%
400,942
+1.6%
0.00%0.0%
Q2 2019$1,515,000394,5650.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders